Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer
NCT04515004Phase 2Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in lung cancer, sponsored by VA Office of Research & Development. Primary endpoint: Delay in the Planned Surgery of >14 Days That is Possibly Related to Study Medication. Started Nov 2023; status: terminated.
02
Conditions
lung cancer
Beyond the preview
Go deeper on NCT04515004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04515004.